Doctor of Osteopathy Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Ryan Johnson

Neurological Surgery Normal, IL Doctor of Osteopathy

NPI 1932559119 CMS profile 2719725

1300 Franklin Ave Ste 110, Normal, IL 61761

Open in the dashboard

General payments

$21,947

247 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ryan Johnson of Normal, IL is reported in the CMS Open Payments database as having received $21,947 across 247 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 79th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $6,563 80
2024 General $2,241 33
2023 General $9,294 102
2022 General $3,766 29
2020 General $82 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ryan Johnson
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Ryan Johnson were reported at $6,563. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Ryan Johnson Neurological Surgery median Middle half National median
2019 $0 $582 $138–$3,006 $163
2020 $82 $294 $76–$2,174 $114
2021 $0 $387 $105–$2,432 $132
2022 $3,766 $542 $139–$2,989 $149
2023 $9,294 $534 $145–$2,697 $160
2024 $2,241 $574 $155–$3,046 $164
2025 $6,563 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Medtronic, Inc. $9,268 105 payments
  2. Globus Medical, Inc. $4,550 31 payments
  3. Spinal Elements, Inc. $3,825 57 payments
  4. NuVasive, Inc. $3,575 44 payments
  5. DePuy Synthes Sales Inc. $221 2 payments
  6. Carlsmed, Inc. $153 1 payment
  7. Orthofix Medical, Inc. $141 2 payments
  8. Kuros Biosciences USA, Inc $88 1 payment
  9. Centinel Spine, LLC $41 1 payment
  10. Ethicon US, LLC $40 1 payment
  11. Other $46 2 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Travel and Lodging $11,961 71 payments
  2. Food and Beverage $9,969 175 payments
  3. Entertainment $17 1 payment
Products named General payments · program years 2020–2025
  1. MAZOR X SYSTEM $5,059 45 payments
  2. Medical Device $2,407 35 payments
  3. Medical Devices $2,196 32 payments
  4. CD HORIZON SPINAL SYSTEM $1,871 20 payments
  5. XLIF $1,501 20 payments
  6. RELINE $1,400 9 payments
  7. SABLE $1,139 3 payments
  8. TLIF $1,043 6 payments
  9. UNID_PASS $885 13 payments
  10. CREO MCS, Fenestrated, Sideloading $810 3 payments
  11. Other $5,738 82 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

236

Median for Neurosurgery: 83

Drug cost

$2,280

Median for Neurosurgery: $872

Branded share of claims

7.6%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Pregabalin Generic 15 $878
Mupirocin Generic 97 $570
Gabapentin Generic 22 $198
Methocarbamol Generic 27 $197
Methylprednisolone Generic 33 $177
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 18 $133
Tizanidine Hcl Generic 24 $127

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 70 billing codes

Paid by Medicare

$140,183

Medicare's payments for the services billed

Medicare patients

167

Average age 72

Services billed

437

95 women, 72 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 41%
Ischemic heart disease 37%
Depression 34%
Chronic kidney disease 26%
COPD 26%
Heart failure 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

247 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record